Preface on Pancreas Adenocarcinoma1
Preface: pancreas adenocarcinoma
Chinese Clinical Oncology
2017;
6
(3)
:23
.
(30 June 2017)
Review Article on Pancreas Adenocarcinoma1
Epidemiology of pancreatic adenocarcinoma
Chinese Clinical Oncology
2017;
6
(3)
:24
.
(30 June 2017)
Preclinical models of pancreatic ductal adenocarcinoma
Chinese Clinical Oncology
2017;
6
(3)
:25
.
(30 June 2017)
Adjuvant and neoadjuvant therapy for resectable pancreatic adenocarcinoma
Chinese Clinical Oncology
2017;
6
(3)
:26
.
(30 June 2017)
Multimodality management of borderline resectable pancreatic adenocarcinoma
Chinese Clinical Oncology
2017;
6
(3)
:27
.
(30 June 2017)
Radiation therapy in the management of pancreatic adenocarcinoma: review of current evidence and future opportunities
Chinese Clinical Oncology
2017;
6
(3)
:28
.
(30 June 2017)
Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017
Chinese Clinical Oncology
2017;
6
(3)
:29
.
(30 June 2017)
Pancreas adenocarcinoma: novel therapeutics
Chinese Clinical Oncology
2017;
6
(3)
:30
.
(30 June 2017)
Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma
Chinese Clinical Oncology
2017;
6
(3)
:31
.
(30 June 2017)
Palliative care and advance care planning for pancreas and other cancers
Chinese Clinical Oncology
2017;
6
(3)
:32
.
(30 June 2017)
Review Article
Isocitrate dehydrogenase mutation as a therapeutic target in gliomas
Chinese Clinical Oncology
2017;
6
(3)
:33
.
(30 June 2017)
Disclosure:
1. The series “Pancreas Adenocarcinoma I” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Eileen M. O’Reilly and Lei Zheng served as the unpaid Guest Editors for the series.
